Fast funding for Chinese healthcare innovators

TF Capital plans to invest its inaugural China-focused VC fund in innovation and technology in that nation's healthcare space. The firm, which has about $50 million to invest, has already made about eight investments, including last week's $10 million series A round for in-licensing play Canbridge Life Sciences Ltd.

"The whole healthcare sector has changed with the booming middle class, and we see a big opportunity here," said TF Capital's Kevin Chiang...